YOLFTbeta
Nanoform Finland Plc

Nanoform Finland Plc

NANOFH · HE · Healthcare / Biotechnology

0.72EUR+0.02 (+2.13%)

Price History

Full chart

Market Stats

Previous Close0.705
Open0.705
Day Range0.678 – 0.72
52-Week Range0.377 – 1.29
Volume76.46K
Market Cap72.03M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.16
Dividend Yield0.00%
Beta0.80
50-Day Avg0.9284
200-Day Avg0.8269

About

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predicts the performance of your molecule in Nanoform's technology. The company was founded in 2008 and is headquartered in Helsinki, Finland.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOProf. Edward Olof Haeggstrom
  • Employees108
  • HeadquartersCultivator II, Helsinki, Finland, 00790, Finland
  • Websitehttps://www.nanoform.com

Leadership

  • Mr. Albert Alexander HaeggstromCFO & Director · b. 1971
  • Prof. Edward Olof HaeggstromCo-Founder & CEO · b. 1969
  • Mr. Henri von HaartmanDirector of Investor Relations
  • Mr. Peter HanninenGeneral Counsel & Chief Development Officer · b. 1988
  • Dr. David RoweHead of Manufacturing · b. 1967
  • Mr. Christian JonesChief Commercial Officer · b. 1980
  • Mr. Antonio Da SilvaChief of Business Operations · b. 1974
  • Ms. Johanna KauseChief Quality Officer · b. 1971
  • Dr. Jamie UnwinVice President of Strategic Insight

Financials

Income Statement

Currency: EUR2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue65.00K235.00K49.09K686.75K1.95M3.49M2.57M2.78M3.55M
Growth (%)-+261.54%-79.11%+1298.87%+184.61%+78.42%-26.41%+8.22%+27.67%
Cost of Revenue160.38K161.62K603.43K216.28K162.38K340.49K849.04K551.98K18.43M
Gross Profit-95.38K73.38K-554.34K470.47K1.79M3.15M1.72M2.23M-14.89M
Gross Margin-146.74%31.22%-1129.16%68.51%91.69%90.24%66.92%80.13%-419.83%
Operating Expense390.74K2.06M6.79M19.89M21.50M24.56M24.19M26.46M7.37M
Operating Income-486.12K-1.99M-7.34M-19.42M-19.71M-21.41M-22.48M-24.24M-22.25M
Operating Margin-747.87%-845.53%-14959.90%-2828.22%-1008.18%-613.90%-875.73%-872.57%-627.55%
EBITDA-419.35K-1.83M-6.94M-17.93M-17.19M-19.25M-17.85M-20.14M-19.01M
EBITDA Margin-645.16%-777.91%-14134.08%-2611.39%-879.56%-552.12%-695.41%-724.96%-536.18%
Net Income-521.27K-2.07M-7.69M-19.44M-19.69M-22.07M-20.76M-23.43M-17.90M
Net Income Margin-801.96%-882.67%-15669.26%-2830.92%-1007.38%-632.99%-808.73%-843.49%-504.74%
R&D452.00K865.00K27.52K1.36M930.10K1.01M998.88K1.56M5.93M
R&D as % of Total Revenue695.38%368.09%56.06%197.56%47.59%28.90%38.92%56.17%167.34%
Interest Expense34.96K86.27K170.43K277.58K783.21K419.75K202.59K41.44K223.00K
Interest Expense % of Total Revenue53.79%36.71%347.16%40.42%40.07%12.04%7.89%1.49%6.29%

Balance Sheet

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets844.73K792.93K8.21M12.91M73.89M99.35M100.64M78.13M71.81M53.98M
Total Liabilities570.41K1.04M3.18M4.98M11.25M14.86M13.43M11.19M11.77M11.20M
Total Equity274.31K-246.96K5.03M7.93M62.64M84.49M87.21M66.95M60.03M42.78M
Cash385.64K98.01K5.59M7.30M61.03M75.73M68.74M14.23M36.47M24.00M
Total Debt350.38K753.60K2.40M3.66M6.87M7.66M6.93M6.26M5.56M6.21M
Net Debt-35.26K655.59K-3.19M-3.64M-54.16M-68.07M-61.81M-7.97M-30.91M-17.79M

Cash Flow

Currency: EUR2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-669.18K-1.50M-5.80M-14.16M-14.35M-20.08M-18.00M-18.28M-17.66M
Investing Cash Flow-92.02K-440.67K-1.88M-4.04M-9.12M-9.62M-35.47M27.44M5.09M
Financing Cash Flow473.57K7.44M9.41M71.86M36.40M22.74M-1.19M13.64M120.00K
Capital Expenditure92.02K440.67K1.88M2.44M7.92M9.13M3.81M1.73M1.03M
Free Cash Flow-761.20K-1.94M-7.68M-16.60M-22.27M-29.21M-21.81M-20.01M-18.70M
Dividends Paid--237.40K------
FCF to OCF113.75%129.30%132.38%117.23%155.20%145.45%121.15%109.47%105.84%
Dividend Paid to FCF---3.09%------

Earnings

Report DateMar 31, 2020Aug 28, 2020Nov 27, 2020Feb 26, 2021May 27, 2021Aug 26, 2021Nov 25, 2021Feb 22, 2022May 24, 2022Aug 25, 2022Nov 29, 2022Feb 28, 2023May 25, 2023Aug 24, 2023Nov 22, 2023Feb 29, 2024May 30, 2024Aug 29, 2024Nov 18, 2024Feb 27, 2025May 20, 2025Aug 21, 2025Nov 12, 2025Feb 26, 2026May 19, 2026Aug 20, 2026Nov 11, 2026
EPS Estimate----0.24-0.13-0.18-0.16-0.18-0.14-0.13-0.15-0.15-0.12-0.12-0.10-0.10--0.06-0.05-0.04-0.06-0.06-0.06-0.05---0.03
EPS Actual-0.07-0.10-0.06-0.06-0.06-0.07-0.06-0.08-0.07-0.08-0.07-0.07-0.06-0.09-0.05-0.07-0.09-0.06-0.06-0.07-0.06-0.07-0.06-0.02-0.04-0.04-
Surprise---75.00%53.85%61.11%62.50%55.56%50.00%38.46%53.33%53.33%50.00%25.00%50.00%30.00%-0.00%-20.00%-75.00%0.00%-16.67%0.00%60.00%---
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap72.03M
Enterprise Value63.72M
Trailing P/E0.00
Forward P/E0.00
Price / Sales13.03
Price / Book2.10
EPS-0.16
Book Value0.424
Revenue (TTM)5.53M
Gross Profit (TTM)5.00M
EBITDA-14.62M
Profit Margin-248.57%
Operating Margin-477.29%
Return on Equity-32.12%
Return on Assets-18.57%
Shares Outstanding85.75M
Shares Float24.67M
Beta0.80
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%